In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...

Brian Grenko of VDE Americas assesses the route to market for perovskite PV products as an alternative to silicon-based ...

Q1 2025 Management View The company announced a strategic restructuring to focus on its LineaRx subsidiary, exiting the DNA Tagging and Security Products and Services segment. This move is expected to ...

The new plan — the fourth by the state’s developers — is the latest flashpoint over what’s to become of the storied campus ...

Announces Exit of DNA Tagging and Security Products and Services Business Segment - - Workforce Reduction of 20% of Headcount ...

Applied DNA Sciences Inc (APDN) reports increased revenues and strategic shifts, while addressing financial hurdles and ...

Let's look at six real-world reasons why companies stick with manual processes and how to tell when automation might be the ...

Here are several reasons why Texas should serve as a blueprint for U.S. energy leadership in the 21st century.

Europe, said Armin Papperger, Rheinmetall chief executive, needed large “champions with a turnover of around €40bn”. This, he ...

Microsoft is publishing for the first time our research into a subgroup within the Russian state actor Seashell Blizzard and ...

Q4 2024 Earnings Call February 12, 2025 2:30 AM ETCompany ParticipantsKarl Hersvik - Chief Executive OfficerDavid Tønne - ...